Paper II
2022 July (Supplementary) (2019 Scheme) · 100 marks · 180 min

Question

Describe the types and grading of astrocytoma

Q114 marksShort Answers

Answer

Astrocytomas are the most common primary glial tumours of the central nervous system.

Types (WHO classification, incorporating molecular features)

  • Diffuse (infiltrating) astrocytomas: The classic progressive spectrum
    • Diffuse astrocytoma, IDH-mutant (WHO Grade 2)
    • Anaplastic astrocytoma, IDH-mutant (WHO Grade 3)
    • Glioblastoma, IDH-wildtype (WHO Grade 4) — most common and most aggressive primary brain tumour in adults
  • Circumscribed astrocytomas (distinct, non-infiltrating, generally better prognosis):
    • Pilocytic astrocytoma (WHO Grade 1) — common in children, often cerebellar

Grading

  • Based on histological features: cellularity, nuclear atypia, mitotic activity, microvascular proliferation, and necrosis
  • Grade 1 (Pilocytic astrocytoma): Low cellularity, biphasic pattern (compact and loose areas), Rosenthal fibres, eosinophilic granular bodies — well-circumscribed, low proliferative activity
  • Grade 2 (Diffuse astrocytoma): Mild hypercellularity, mild nuclear atypia, no mitoses/necrosis/microvascular proliferation
  • Grade 3 (Anaplastic astrocytoma): Increased cellularity, marked nuclear atypia, brisk mitotic activity, no necrosis
  • Grade 4 (Glioblastoma): All features of grade 3, plus microvascular proliferation and/or necrosis (classically “pseudopalisading necrosis” — tumour cells arranged radially around necrotic foci) — the defining features that upgrade to grade 4

Molecular markers of prognostic significance

  • IDH1/IDH2 mutation status — mutant tumours have significantly better prognosis than IDH-wildtype
  • MGMT promoter methylation — predicts better response to temozolomide chemotherapy
  • 1p/19q co-deletion — favours oligodendroglioma diagnosis over astrocytoma, better prognosis

Revise MBBS
Preview